ArticleJournal of the National Cancer Institute2019

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.

Motonari Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.